ÂÜÀòÂÒÂ×

Dr. Lynn Carter provides CMC, pharmaceutical development, and analytical chemistry expertise for a variety of dosage forms in all stages of development. She specializes in CMC project leadership, strategic and technical input on all aspects of CMC development, and authoring of regulatory submissions.

As a consultant, Dr. Carter has worked with a wide range of clients, from large pharma to small virtual companies. She had an eleven-year career at GlaxoSmithKline during which she rose to the position of Manager, PD Operations. Before that she held positions at Procter & Gamble and Pfizer.

Dr. Carter has a Ph.D. Analytical Chemistry, from the University of Cincinnati and a BS in Chemistry from Duke University.